TECHNIP SA 27/04/2007 Combined
1Approve Company Financial Statements
21)Approval of the appropriation of income and of the dividend;2)Payment of an exceptional dividend out of reserve accounts.
3Presentation of the Group's Report and Financial Statements.
4Approval of regulated related-party agreements :
5Approve Directors' Attendance Fees.
6Election of M. Thierry Pilenko as Director for a period of 4 years.
7Election of M. Pascal Colombani as Director for a period of 4 years.
8Election of M John CG O Leary as Director for a period of 4 years.
9Election of Mme Germaine Gibara as Director for a period of 4 years.
10Reappointment of M. Olivier Appert as Director for a period of 4 years.
11Reappointment of M. Jacques Deyirmendjian as Director for a period of 4 years.
12Reappointment of M. Jean-Pierre Lamoure as Director for a period of 4 years.
13Reappointment of M. Daniel Lebègue as Director for a period of 4 years.
14Reappointment of M. Roger M. Milgrim as Director for a period of 4 years.
15Reappointment of M. Rolf E. Rolfsen as Director for a period of 4 years.
16Reappointment of M. Bruno Weymuller as Director for a period of 4 years.
17Elect Auditex as Substitute External Auditor for a period of 3 years.
18Approve buy-back of the company shares.
191)Amend the length of the mandate of Directors;2)Allow for video-conference of the Board meetings and set up the new French legal identification with the number of shares confirmed by the bank at the legal "record date" of D-3 working days.
20Global authorization to issue with pre-emptive subscription right shares or other securities giving way to new capital. Authorize an operation up to € 37 500 000 in nominal value; Authorize the issuance of related securities up to an amount of € 2 500 000 000 - authorization valid for a period of 26 months .
21Global allowance for the issuance of capital related securities without pre-emptive right possibly as a payment for public exchange offers .
22Global allowance for the issuance of capital related securities without pre-emptive right.
23Increase authorized capital by transfer of reserves. Authorize an operation up to € 75 000 000 in nominal value. Authorization valid for a period of 26 months.
24Delegation to issue shares and capital securities as consideration for contributions in kind made to the company.
25Approve capital Increase for the employees.
26Approve capital Increase for the employees :
27Issue restricted shares for employees and managers.
28New stock option plans
29Adopt poison-pill style defence: keep active the rights authorizations under a public offer for company' shares.
30Delegation of powers for the completion of formalities